INTRODUCTION
Understanding the regulation of lipogenesis is critical since dysregulated lipogenesis and triglyceride levels are often linked to pathological conditions including obesity, diabetes, and cardiovascular disease. Fatty acid and triglyceride synthesis is under tight nutritional and hormonal control (Wong and Sul, 2010) . After a meal, insulin secretion increases, causing lipogenic tissues such as liver and adipose to convert excess glucose to fatty acids (de novo lipogenesis), using NADPH as reducing equivalents. Fatty acids are then esterified into triglycerides. In liver, triglycerides are packaged into VLDL for secretion, whereas triglycerides in adipose tissue are stored and later released to the circulation as fatty acids, for use by other tissues during periods of energy demand. Enzymes involved in fatty acid and fat synthesis, such as fatty acid synthase (FAS), are coordinately regulated at the transcriptional level in response to changing conditions-transcription is low during fasting, but drastically increases in response to feeding/insulin. The effect of insulin on metabolic regulation is primarily mediated through activation of the PI3K pathway and its downstream kinases, including PKB/ Akt, as well as through activation of protein phosphatase (PP1) (Brady and Saltiel, 2001; Taniguchi et al., 2006a; Bakan and Laplante, 2012) . However, the effect of insulin on chromatin remodeling that may be required for activation of the lipogenic program is not understood.
By catalyzing seven reactions in fatty acid synthesis, FAS plays a central role in de novo lipogenesis. Due to its regulation primarily at the transcriptional level, FAS provides an excellent model to dissect the transcriptional activation of lipogenesis in response to feeding/insulin Sul, 1988, 1989) . We have previously shown that binding of the upstream stimulatory factor-1/2 (USF-1/2) heterodimer to the À65 E-box is required for FAS promoter activation in response to feeding/ insulin (Moustaïd et al., 1994; Moustaïd et al., 1993) . The critical role of USF in lipogenic gene transcription has been demonstrated in vivo in USF knockout mice that have significantly impaired lipogenic gene induction (Casado et al., 1999) . Quantitative trait mapping studies have identified that USF-1 may be a candidate gene for familial combined hyperlipidemia (Pajukanta et al., 2004) . In addition to USF, the role of sterol regulatory element-binding protein-1c in lipogenesis is now well documented Sul, 2010, Horton et al., 2002) . In this regard, we have shown that SREBP-1c, when induced by insulin, binds to the SRE present nearby the E-box of the FAS promoter, but recruitment of SREBP-1c to the FAS promoter is dependent on USF binding to the À65 E-box and the direct interaction of USF with SREBP-1c (Latasa et al., , 2003 Griffin et al., 2007) . We recently have shown that in response to feeding/insulin, USF-1 is phosphorylated at S262 by DNA-PK that is activated by PP1 and that, upon phosphorylation, USF-1 recruits and is acetylated at K237 by P/CAF ; (legend continued on next page)
Molecular Cell
BAF60c in Lipogenesis ). Together, these results indicate that phosphorylation-dependent acetylation of USF-1 functions as a sensor for nutritional/insulin status to activate FAS transcription. Many other lipogenic genes contain closely spaced E-boxes and SREs in their proximal promoter regions, and therefore may also be subject to transcriptional regulation by USF-1. Along with FAS, by examining mitochondrial glycerol-3-phosphate acyltransferase (mGPAT), which catalyzes the initial esterification step for triglyceride synthesis, we have demonstrated that coordinate induction of lipogenic gene transcription in response to feeding/insulin occurs via this common mechanism (Griffin et al., 2007) . Dynamic chromatin structure plays an essential role in the control of gene transcription. Although not much is known, chromatin remodeling is predicted to be an important aspect governing metabolic gene regulation during different nutritional and hormonal conditions. The SWI/SNF complex carries out chromatin remodeling and is evolutionarily conserved from yeast to mammals (Hargreaves and Crabtree, 2011, Becker and Hö rz, 2002) . Within the mammalian SWI/SNF complex, the BAF (Brg1/ Brm-associated factor) complex is composed of a core ATPase, Brg1/BAF190 or Brm, and other BAF subunits, such as BAF155, BAF170, and BAF250, which act as modulators, as well as BAF57 and BAF60, which may provide the interaction of the BAF complex with transcriptional machinery (Hargreaves and Crabtree, 2011; Ryme et al., 2009 ). These BAF subunits are thought to be present in the nucleus to control transcription by forming BAF or the BAF-related chromatin remodeling complex. The mode of regulation of specific components of the BAF complex, and the signaling pathways that lead to recruitment of specific BAF complexes for chromatin remodeling, have not been well delineated.
BAF60 associates with Brg1/BAF190, potentially functioning as a bridge between DNA-binding transcription factors and other BAF subunits (Hsiao et al., 2003; Ito et al., 2001; Li et al., 2008) . There are three isoforms of BAF60: BAF60a, BAF60b, and BAF60c. These are expressed differentially in various tissues, suggesting a tissue-specific role for BAF60 isoforms, perhaps by association with distinct regulators. For example, BAF60a may be involved in tumor suppression and fatty acid metabolism by interacting with p53 and PGC1a, respectively (Li et al., 2008; Oh et al., 2008) . On the other hand, BAF60c may play a role in heart development (Lickert et al., 2004; Takeuchi et al., 2007) . BAF60c has also been reported to be important for muscle gene expression by interacting with MyoD (Forcales et al., 2012; Simone et al., 2004) . However, how or whether BAF60 isoforms respond to physiological stimuli to associate with specific transcription factors is not well understood.
Here, we show that BAF60c, along with other BAF subunits that include Brg1/BAF190, BAF155, and BAF250, forms the lipoBAF complex for chromatin remodeling that is required for activation of the lipogenic program. USF-1, which is phosphorylated by DNA-PK and then acetylated by P/CAF, recruits BAF60c. BAF60c is phosporylated at S247 by aPKC in response to feeding/insulin. Phosphorylated BAF60c translocates from the cytosol to the nucleus and directly interacts with phosphorylated/acetylated USF, thus allowing recruitment of lipoBAF and remodeling of chromatin to activate lipogenic genes.
RESULTS
Identification of BAF60c as a USF-Interacting Protein USF plays a pivotal role as a molecular switch by recruiting distinct transcription factors and coregulators in a fasting/feedingdependent manner . To identify additional USF-interacting factors, we performed tandem affinity purification (TAP) using USF-1 followed by mass spectrometry (MS) analysis. We identified three BAF subunits, BAF60c, BAF155, and Brg1/BAF190. Immunoblotting of the TAP eluates confirmed the presence of these BAF subunits that copurified with TAPtagged USF-1, but not with the control TAP-tag ( Figure 1A , left). We detected these BAF subunits in the lipogenic tissues, liver, and adipose tissue ( Figure 1A , right), as well as in other tissues examined ( Figure S1 available online).
Since BAF60 is known to function as an anchor point between transcription factors and the BAF complex, we first tested the interaction of BAF60c with USF. In cells overexpressing HAtagged BAF60c and Flag-tagged USF-1, BAF60c copurified with USF-1 by TAP (Figure 1Ba ). We also detected an interaction between USF-1 and BAF60c in cells by coimmunoprecipitation (coIP) (Figure 1Bb ). The interaction between endogenous USF-1 and BAF60c was detected by coIP in liver extracts from fed mice, but not from fasted mice (Figure 1Bc) . Next, by GST pulldown, we established the domain of USF-1 required for the interaction with BAF60c in vitro. BAF60c directly interacts with USF-1. Deletion of the bHLH domain of USF-1 prevented the interaction with BAF60c and is therefore required ( Figure 1C ). The bHLH domain of USF-1 contains K237 that we previously have shown is acetylated by P/CAF in response to feeding/ insulin, suggesting a potential role for USF-1 K237 acetylation in the USF/BAF60 interaction. As predicted, hepatic messenger RNA (mRNA) levels of FAS and mGPAT were decreased upon fasting and markedly increased in response to feeding (Figure 1D, left) . However, BAF60c mRNA levels did not change during fasting/feeding. We observed similar results at the protein level. Unlike FAS protein, which was barely detectable in fasting but markedly increased in the fed condition, BAF60c protein levels did not change significantly with nutritional status (Figure 1D, right) . Parenthetically, expression of another BAF60 isoform, BAF60a, which has been reported to activate fatty acid oxidation, was decreased after feeding ( Figure 1D, left) . Overall, we conclude that BAF60c expression remained the same in fasted and fed conditions.
BAF60c Binds and Activates the FAS Promoter
We next investigated whether the BAF complex is recruited to the FAS promoter upon interaction of BAF60c with USF in response to feeding/insulin. Chromatin immunoprecipitation (ChIP) using livers from transgenic mice expressing a CAT reporter gene driven by the À444 FAS promoter (Latasa et al., 2003; Latasa et al., 2000; Moon et al., 2000) detected binding of USF to the FAS promoter in both the fasted and fed states (Wang and Sul, 1995) . More importantly, the promoter region of the FAS-CAT transgene was occupied by all the identified USF-1-interacting BAF subunits, including BAF60c, BAF155, and Brg1/BAF190, ( Figure 1E ) in the fed state only. We found that these BAF subunits are part of the BAF, but not the PBAF (Polybromo-associated BAF), complex (Wang et al., 1996; Thompson, 2009 ), because we detected BAF250 normally found in BAF complex but not BAF180 or BAF200, which are hallmarks of the PBAF complex (Ryme et al., 2009) (Figure S2 , left). CoIP showed strong interaction of BAF250, but a minimal interaction of BAF180 and BAF200, with USF-1 and BAF60c in livers of fed mice ( Figure S2 , right). ChIP also detected recruitment of BAF60c to the proximal promoter region of the endogenous FAS gene only in the fed state (Figure 1Fa ). However, BAF60a and BAF60b were not detected. We also detected recruitment of BAF60c, but not other BAF60c isoforms, in the proximal promoter regions of other lipogenic genes including mGPAT, ACC, ACL, and SREBP-1c, which all contain an E-box. Thus, BAF60c is the specific isoform recruited to lipogenic promoters upon feeding. In contrast to the lipogenic genes, recruitment of BAF60a was detected on the FA oxidative genes, Acaa1b and Acoxl, only in the fasted state. Furthermore, re-ChIP experiments with USF-1 antibody followed by BAF60c antibody showed recruitment of USF-1 and BAF60c to the same lipogenic promoter regions (Figure 1Fb ). We also detected BAF60c bound to the FAS promoter in the presence of insulin in HepG2 cells, whereas USF-1 was bound both in the presence and absence of insulin ( Figure 1G, left) . The re-ChIP also showed recruitment of BAF60c and USF-1 at the same FAS promoter region in HepG2 cells treated with insulin ( Figure 1G, right) . Overall, these results demonstrate that BAF60c recruitment through USF-1 in response to feeding/insulin is specific to lipogenic genes but not oxidative genes.
We next tested the functional significance of BAF60c recruitment by USF to lipogenic gene promoters. Transfecting USF-1 along with the À444 FAS promoter-luciferase construct increased luciferase activity by approximately 3-fold. While cotransfection of BAF60c alone did not have a significant effect, cotransfection of both USF-1 and BAF60c resulted in a further 3-fold increase in FAS promoter activity ( Figure 1H ). The degree of FAS promoter activation by BAF60c was dose dependent (data not shown). Conversely, FAS promoter activity was decreased by more than 70% upon short hairpin RNA (shRNA)-mediated knockdown of BAF60c that decreased BAF60c protein levels by 80% ( Figure 1I ). Apart from the FAS and mGPAT genes that we previously studied ), the role of USF in insulin-induced activation has not been documented for other lipogenic genes. We therefore performed USF-1 knockdown by using lentiviral infection of USF-1 shRNA in HepG2 cells, which decreased USF-1 protein level by more than 70% ( Figure 1J , left). The recruitment of BAF60c on the FAS promoter by ChIP was markedly decreased in these cells even when treated with insulin ( Figure 1J , middle). Expression of various lipogenic genes was increased upon insulin treatment of HepG2 cells, which was substantially blunted by USF-1 knockdown. Expression of CPT1, one of the oxidative genes, showed no change ( Figure 1J , right). Overall, these results show that BAF60c was recruited by USF-1 and the recruitment of BAF60c in response to feeding/insulin is linked to lipogenic gene promoter activation.
BAF60c Phosphorylation at S247 Brings Its Nuclear Translocation in Response to Insulin/Feeding
By MS analysis, we detected S247 phosphorylation of BAF60c. In fact, the NetPhos program indicated S247 as the most probable serine residue within BAF60c to be phosphorylated. Although S247 of BAF60c and its nearby amino acids are highly conserved among mammals ( Figure S3 , left), this specific serine residue is not conserved in lower organisms ( Figure S3 , right). Interestingly, S247 is also not found in other BAF60 isoforms, suggesting that S247 phosphorylation is unique to the BAF60c function. We generated an antibody against BAF60c phosphorylated at S247 peptide. The antibody specifically recognized the phosphorylated BAF60c since BAF60c S247A mutant did not show signal ( Figure 2A ). Using this antibody, we could detect S247 phosphorylation of BAF60c in livers of fed, but not fasted, mice (Figure 2B, left) . A similar increase in S247 phosphorylation of BAF60c was also detected in HepG2 cells upon insulin treatment ( Figure 2B , right). These results demonstrate that BAF60c is phosphorylated at S247 in response to feeding/insulin.
In general, BAF subunits have been regarded as nuclear proteins. We, however, detected BAF60c in both nuclear and cytosolic fractions after cell fractionation of livers ( Figure 2C ). Moreover, we detected greater BAF60c levels in the nuclear fraction of livers from fed mice compared to fasted mice (Figure 2C, left) . An increase in BAF60c levels was also detected in the nuclear fraction of HepG2 cells after insulin treatment (Figure 2D, middle) . Conversely, a decrease in BAF60c levels was detected in the cytosolic fractions by feeding/insulin treatment ( Figure 2D , right). A similar insulin-mediated BAF60c translocation to the nucleus was detected by immunostaining of HepG2 cells ( Figure 2E , left). In addition, we detected a diffuse signal of BAF60c-GFP throughout the cells upon transfection into 293FT cells in the absence of insulin, and insulin treatment induced localization of BAF60c-GFP in the nucleus ( Figure 2E , right). Furthermore, comparison of immunostaining of all three endogenous BAF60 isoforms in HepG2 cells clearly showed that, unlike BAF60c, BAF60a was mainly found in the nucleus at all times and BAF60b was barely detectable ( Figure 2F , top). BAF60c was also detected by immunostaining throughout cells in livers of fasted mice, but was higher in the nucleus of fed mice ( Figure 2F , bottom). We also detected BAF60c phosphorylated at S247 in the nuclear, but not in the cytosolic fraction in HepG2 cells treated with insulin ( Figure 2G , left). S247 phosphorylated BAF60c was also clearly detected in livers of fed, but not fasted, mice ( Figure 2C and F bottom). Furthermore, unlike wildtype BAF60c, the nonphosphorylatable S247A mutant BAF60c remained in the cytosolic compartment even when treated with insulin ( Figure 2G ), demonstrating the importance of S247 phosphorylation for its nuclear localization.
BAF60c Phosphorylation Allows Its Interaction with USF for FAS Promoter Activation
Next, we tested whether phosphorylation of BAF60c affects its interaction with USF-1. We cotransfected Flag-tagged USF-1 with HA-tagged wild-type BAF60c, S247A, or phosphorylationmimicking S247D mutant BAF60c ( Figure 3A , left) and the cells were treated with insulin. We verified similar levels of wild-type, S247A, and S247D BAF60c protein levels ( Figure 3A , left). We found that both the wild-type and S247D mutant BAF60c were able to interact with USF-1, but the S247A mutant had a markedly decreased interaction ( Figure 3A , right), indicating that S247 phosphorylation of BAF60c is critical for its interaction with USF. In support of this, short peptides containing wild-type S247, but not S247A, competed out the interaction between USF-1 and BAF60c ( Figure 3B , left). When cells were transfected with only USF-1, the interaction between USF-1 and endogenous BAF60c was also disrupted in the presence of S247 but not the S247A peptide ( Figure 3B , right). Overall, these data suggest that BAF60c phosphorylated at S247 interacts with USF-1 with a higher affinity, and the region containing S247 is the most likely site of interaction with USF-1. Next, we incubated bacterially expressed GST-USF-1 with in vitro-translated wildtype BAF60c or S247A BAF60c mutant. Compare to the wildtype in vitro-translated BAF60c, which was efficiently pulled down by USF-1, the S247A mutant was poorly pulled down, even when we used a much higher amount ( Figure 3C, left) . Furthermore, S247D short peptide, but not S247A peptide could compete out GST-USF-1 pulldown of BAF60c ( Figure 3C, right) . These results further demonstrate the critical role of S247 phosphorylation of BAF60c in its interaction with USF.
We tested the functional significance of BAF60c S247 phosphorylation using FAS-promoter reporter assay. Wild-type or the S247D BAF60c mutant both increased USF-dependent FAS promoter activation by 4-fold ( Figure 3D ). In contrast, the S247A mutant BAF60c did not. Furthermore, using ChIP, we detected decreased recruitment of the S247A mutant BAF60c to the FAS promoter in comparison to wild-type or the S247D BAF60c mutant ( Figure 3E ). Overall, these results indicate that S247 phosphorylation of BAF60c governs its nuclear localization and interaction with USF-1 for the activation of FAS promoter activity.
aPKC Phosphorylates BAF60c at S247 in Response to Insulin We next attempted to identify the specific kinase that catalyzes the phosphorylation of S247 in response to feeding/insulin. A review of phospho-protein databases predicted that a member of the protein kinase C (PKC) family may phosphorylate the S247 of BAF60c. Among PKC isoforms, atypical PKCz and PKCl are known to be activated by PI3K to mediate downstream insulin signaling (Taniguchi et al., 2006b) . Indeed, we detected in vitro phosphorylation of S247 of BAF60c by both PKCl and PKCz. Moreover, S247 phosphorylation was abolished upon addition of a myristoylated inhibitory peptide (Pep) (Farese and Sajan, 2010) of PKCl and PKCz (Figure 4A ). In addition, we easily detected phosphorylation of wild-type BAF60c, but not the S247A mutant, by either PKCz or PKCl ( Figure 4B ). Based on these results, we conclude that the S247 of BAF60c is a target of aPKC. We then tested S247 phosphorylation of BAF60c in cells by aPKC in cultured cells. We clearly detected S247 phosphorylation of BAF60c in cells overexpression BAF60c, which was abolished in cells treated with cell-permeable myristoylated inhibitory peptide ( Figure 4C ). Additionally, overexpression of either PKCz ( Figure 4D , left) or PKCl (data not shown) along with BAF60c greatly increased BAF60c phosphorylation at S247, while treatment with the aPKC inhibitor GF109203X prevented S247 phosphorylation ( Figure 4D , right) (Uberall et al., 1999) . Furthermore, in comparison to wild-type PKCz, cotransfection of dominant negative PKCz into 293FT cells greatly diminished BAF60c phosphorylation ( Figure 4E ), as well as the interaction between endogenous BAF60c and USF-1 (Figure 4F) , showing the functional role of phosphorylation for its interaction with USF-1. Moreover, BAF60c S247 phosphorylation was also decreased significantly upon small interfering RNA (siRNA)-mediated knockdown of PKCz and PKCl by 80% ( Figure 4G ), and mutant S247A BAF60c could not be phosphorylated either in control or aPKC siRNA-transfected cells. Importantly, FAS promoter activation was markedly lower in aPKC siRNA-transfected cells ( Figure 4H ). By infecting adenoviral dominant negative PKCz in mice, we also examined the function of aPKCmediated phosphorylation of BAF60c in vivo. In these mice, expression level of dominant negative PKCz was higher than endogenous PKCz by 3.7-fold ( Figure 4I, left) . Immunoblotting with an antibody that detects both the wild-type and dominant negative PKCz further confirmed the overexpression of dominant negative PKCz. Although BAF60c levels remained the same, S247 phosphorylation of BAF60c was greatly diminished by overexpression of dominant negative PKCz. In these mice, expression of lipogenic genes was substantially decreased, whereas CPT1 expression did not change (Figure 4I, right) . Overall, these results show that S247 of BAF60c is phosphorylated specifically by aPKC to mediate the effect of insulin on lipogenic gene activation.
Posttranslational Modifications of Both BAF60c and USF Are Critical for Their Interaction and Function
Since BAF60c interacts with USF-1 through the domain containing acetylated K237, we tested whether acetylation of USF-1 could affect its interaction with BAF60c. In coIP experiments, wild-type USF and the K237A mutant, which mimics hyperacetylation, but not the K237R mutant clearly showed an interaction with the wild-type and S247D mutant BAF60c ( Figure 5A ). Similar results were obtained with hyperacetylation-mimicking K237Q USF (data not shown), whereas S247A BAF60c could not interact with USF-1. In vitro interaction assays also showed that only hyperacetylated USF-1 was able to interact with wild-type but not with the S247A BAF60c mutant, while nonacetylated USF failed to interact with either wild-type or S247A BAF60c mutant ( Figure 5B ).
Next, by ChIP, we detected wild-type or S247D BAF60c mutant bound to the FAS promoter in cells transfected with wild-type or K237A USF-1 mutant in insulin-treated cells (Figure 5C ). S247A BAF60c mutant was not bound to the FAS promoter, regardless of the forms of USF-1 that were cotransfected. None of the BAF60c forms were detected in association with the FAS promoter region when the K237R USF-1 mutant was cotransfected. Furthermore, the FAS promoter was activated to the highest degree only when the wild-type or the S247D BAF60c mutant were cotransfected with the wild-type or the K237A USF-1 mutant ( Figure 5D ), but not with the S247A BAF60c or K237R USF-1 mutant. In HepG2 cells, BAF60c phosphorylation at S247, as well as USF-1 phosphorylation at S262 and acetylation at K237, was detected only upon insulin treatment ( Figure 5E ). These data clearly show that posttranslational modifications of both BAF60c (S247 phosphorylation) and USF (K237 acetylation) are required for their interaction and binding to the FAS promoter region for transcriptional activation. In DNA-PK-deficient SCID mice, phosphorylation at S262 of USF is greatly reduced, which in turn results in a decrease in acetylation of K237 of USF. We thus examined whether recruitment of BAF60c to the FAS promoter by USF was altered in SCID mice. As we reported previously, unlike in wild-type mice, FAS protein levels were not increased significantly by feeding in SCID mice. Total BAF60c levels remained the same in both wild-type and SCID mice in fasted and fed states. However, while phosphorylation of BAF60c at S247 was significantly higher in wild-type mice upon feeding, this feeding-induced BAF60c phosphorylation was not detected in SCID mice ( Figure 5F ). As we have previously shown, total USF-1 protein levels remained the same, but K237 acetylation and S262 phosphorylation of USF-1 were substantially higher in wild-type mice upon feeding. The total BAF60c or S247 phosphorylated BAF60c that coimmunoprecipitated with USF was substantially higher in wild-type mice upon feeding also. In contrast, we could not detect 237K acetylation of USF in SCID mice in either the fasted or fed states. The amount of BAF60c that coimmunoprecipitated with USF remained the same in SCID mice, albeit lower than wild-type mice. Furthermore, S247 phosphorylation of BAF60c was not detectable in either fasted or fed SCID mice ( Figure 5G ). As expected, in ChIP, the total USF-1 bound to the FAS and mGPAT promoter regions remained the same in wild-type and SCID mice in both fasted and fed conditions ( Figure 5H, left) . And as we previously reported, the phosphorylated and acetylated USF was bound to the FAS promoter only in the fed state, but not in the fasted state. In contrast, BAF60c was bound to the FAS and mGPAT promoters only in wild-type mice in the fed state, but not in the fasted state. More importantly, we could not detect BAF60c in either the fasted or fed SCID mice ( Figure 5H ). These data show that USF phosphorylation by DNA-PK, which leads to subsequent USF acetylation, is required for the recruitment of BAF60c to lipogenic gene promoters.
BAF60c Promotes Chromatin Remodeling of Lipogenic Genes in Response to Insulin
BAF60c has been proposed to serve as a bridge between transcription factors and the ATPase-dependent chromatin remodeling BAF complex. We therefore investigated whether chromatin accessibility is altered during lipogenic activation. Nuclear extracts from HepG2 cells were incubated with MNase that preferentially cuts DNA of nucleosome-free regions, including regions between nucleosomes (Engel and Yamamoto, 2011) . A periodic pattern of MNase accessibility was observed in control cells indicating nucleosome positioning at the proximal FAS promoter region ( Figure 6A ). Treatment with insulin for 10 min caused a marked increase in accessibility around the first two nucleosomes from the transcription start site, indicating insulin-mediated remodeling of chromatin structure ( Figure 6A ). Change in accessibility was detectable as early as 5 min after the addition of insulin ( Figure 6B ). H3 phosphorylation and acetylation have been reported to play a role in recruitment of the Brg1 containing chromatin remodeling BAF complex (Drobic et al., 2010; Vicent et al., 2006 Vicent et al., , 2009 ), so we examined occupancy of histones as well as Pol II in chromatin remodeling. By ChIP, we detected that H1, H2A, and H2B were bound to the FAS promoter in control cells or in livers of fasted mice, but the signal was weak upon insulin treatment or feeding, respectively ( Figure 6C, left) . Pol II and acetylated H3 at K14 and phosphorylated H3 at S10 were bound to the FAS promoter in feeding, but not in fasting ( Figure 6C, right) . These results suggest that not only BAF complex but also histone modification occurs during chromatin remodeling of the FAS promoter with insulin/feeding.
We then performed MNase assay in HepG2 cells after overexpression or knockdown of BAF60c. Overexpression of BAF60c by adenoviral infection increased BAF60c protein (Figure 6Da , top) and mRNA levels (Figure 6Dd ). In the absence of insulin, there were no detectable differences in chromatin structure between control and BAF60c-overexpressing cells as tested by digestion with MNase. Upon insulin treatment, control cells showed the accessibility of the proximal FAS promoter region increased by 30%, while in BAF60c-overexpressing cells accessibility increased by more than 50% (Figure 6Da) . Similar results were obtained with the mGPAT promoter showing its accessibility increasing by 65% in BAF60c-overexpressing cells after insulin treatment versus only 40% in control cells. These increases in accessibility were lipogenic gene specific and were not seen in the Acaa1b promoter, either with or without BAF60c overexpression. In addition, ChIP analysis of the FAS promoter region showed a 4-fold increased binding of H3-S10 phosphorylation and H3-K14 acetylation in BAF60c-overexpressing cells over control cells (Figure 6Db ). Pol II binding was increased by 2-fold also. In contrast, ChIP with a histone H1 antibody did not show a significant change. Nuclear run-on assays showed that FAS transcription in HepG2 cells started to increase significantly at 10 min after insulin addition, further increasing by 8-and 15-fold at 30 and 60 min, respectively. Importantly, cells overexpressing BAF60c showed an even greater increase in FAS transcription. A significant increase was easily detectable 5 min after insulin treatment, and transcription was 19-fold and 37-fold higher at 30 and 60 min, respectively, showing enhancement of insulin-mediated FAS transcription by BAF60c overexpression (Figure 6Dc) . Similarly, mRNA levels of various other lipogenic enzymes were significantly higher upon BAF60c overexpression, while mRNA levels of CPT1 did not change (Figure 6Dd) . In contrast, shRNA adenovirus-mediated BAF60c knockdown cells that had 90% lower BAF60c showed a blunted insulin effect on FAS and mGPAT promoter accessibility (Figure 6E ). ChIP analysis showed that BAF60c knockdown decreased histone H3-S10 phosphorylation and H3-K14 acetylation, as well as Pol II binding to the FAS promoter region, without any changes in binding of histone H1 (Figure 6Eb) . Consequently, BAF60c knockdown cells showed a significant blunting in the insulin mediated increase in FAS transcription (Figure 6Ec ). mRNA levels of lipogenic enzymes were all notably lower in BAF60c knockdown cells, while CPT1 mRNA levels were not altered (Figure 6Ed ). Overall, we conclude that BAF60c is specific for chromatin remodeling and transcription of lipogenic genes in response to insulin.
BAF60c Induces Lipogenesis In Vivo
We next examined the biological function of BAF60c in vivo by adenoviral overexpression. Administration of BAF60c adenovirus by tail-vein injection increased liver BAF60c protein levels by approximately 3-fold ( Figure 7A , top left). In these mice, even in the fasted state, hepatic expression levels of lipogenic genes including FAS, ACC, SCD1, mGPAT, and SREBP-1c, but not CPT1, were significantly higher than those in control mice ( Figure 7A , top middle). We also detected higher FAS protein levels upon BAF60c overexpression (data not shown). Nascent nuclear RNA levels of the lipogenic genes also showed a similar increase upon BAF60c overexpression ( Figure 7A , top right). Next, we measured de novo lipogenesis by employing a heavy water labeling technique. Although newly synthesized palmitate remained low in the fasted state in control mice as expected, BAF60c overexpression increased de novo fatty acid synthesis by approximately 2-fold ( Figure 7A, bottom left) . Hepatic triglyceride levels also were significantly higher in livers of BAF60c-overexpressing mice ( Figure 7A, bottom right) . We performed microarray analysis comparing global liver gene expression patterns between wild-type mice and mice overexpressing BAF60c. Indeed, we found that BAF60c overexpression activates the lipogenic program by increasing expression of a variety of lipogenic enzymes, including FAS, ACC, ACL, SCD1, and mGPAT, as well as malic enzyme, G6PDH, and gluconolactone dehydrogenase for NADPH synthesis (Table S1 ). In addition, SREBP-1, which itself is induced upon feeding/insulin treatment and is involved in the activation of lipogenic genes (Horton , 1998 , , Horton et al., 2002 , was also identified to be activated upon BAF60c overexpression. Thus, forced overexpression of BAF60c enhanced lipogenesis in vivo even in the fasted condition when no significant de novo lipogenesis is expected to normally occur.
In contrast, adenovirus-mediated knockdown of BAF60c which caused an over 80% decrease in BAF60c protein levels resulted in a significantly lower hepatic expression of lipogenic genes even in the fed state, in comparison to control scrambled shRNA adenovirus ( Figure 7B, top right) . Control CPT1a expression levels did not change. We also detected a significant decrease in de novo lipogenesis in BAF60c knockdown mice in the fed state ( Figure 7B, bottom left) . The changes in de novo lipogenesis were reflected in total hepatic triglyceride levels that were decreased by approximately 50% in BAF60c knockdown mice ( Figure 7B , bottom right). Since we have previously shown that USF recruits SREBP-1c to nearby SREs by direct interaction and since PI3K-Akt is known to induce lipogenesis through SREBP-1c, we tested involvement of the PI3K-Akt pathway in BAF60c function in lipogenesis by adenoviral delivery for overexpression of Akt upon BAF60c knockdown. As above, BAF60c expression was decreased more than 80%, whereas Akt expression was increased by 4-fold to 5-fold in livers of mice upon adenovial infection of BAF60c shRNA or Akt, respectively (Figure 7Ca, left) . As expected, expression of lipogenic genes was decreased considerably upon BAF60 knockdown, whereas overexpression of Akt alone greatly increased expression levels. However, the increase from Akt overexpression was substantially diminished in BAF60c knockdown mice (Figure 7Ca, right) . Infection of BAF60 shRNA in HepG2 cells decreased BAF60 expression by 95% and Akt adenovirus increased Akt expression by 5-fold (Figure 7Cb, left) . Similar to the in vivo results, overexpression of Akt alone markedly increased lipogenic gene expression in HepG2 cells, which was diminished in BAF60c knockdown cells (Figure 7Cb, right) . These results suggest that PI3K-Akt pathway can induce lipogenic gene expression, but Akt cannot fully induce lipogenic genes in the absence of BAF60c. We predict that Akt increases SREBP-1c activation and/or expression to interact with USF. Overall, our in vivo results on BAF60c clearly show the critical role BAF60c plays in the feeding/insulin-induced activation of lipogenic genes.
DISCUSSION
A central issue in understanding metabolic regulation is the definition of coordinated molecular strategies that underlie the transition from fasting to feeding along specific signal transduction pathways. Transcriptional activation of lipogenic enzymes to induce lipogenesis is one such process. In this regard, chromatin remodeling by SWI/SNF-related complexes, such as mammalian BAF, is indispensable for regulated transcription. However, regulation of the BAF complex in response to cellular signaling is not well understood. Here, we determine that BAF60c recruits other BAF subunits including BAF155 and BAF190 to form the lipoBAF complex to activate lipogenic gene transcription. We further demonstrate that this regulation is based on the phosphorylation-dependent nuclear translocation of BAF60c, and its interaction with USF-1. And, finally, we demonstrate that BAF60c phopshorylation by aPKC and USF-1 phosphorylation by DNA-PK are required for their interaction, converging two branches of insulin signaling for transcriptional activation of lipogenesis ( Figure 7C ).
BAF60c and Its Associated Subunits Define the lipoBAF
Complex that Is Specific for Chromatin Remodeling for Lipogenic Gene Transcription BAF60 is thought to form a recruitment bridge between DNA binding factors and BAF subunits in regulating gene transcription. Three distinct isoforms of BAF60, BAF60a, BAF60b, and BAF60c, have been identified and are able to form distinct complexes based on tissue and promoter context to regulate sophisticated and diverse cellular functions. Our present study shows that USF interacts with BAF60c, but not BAF60a or BAF60b, to recruit other BAF subunits, including BAF155, BAF190, and BAF250, to lipogenic gene promoters to increase lipogenesis in response to feeding/insulin treatment. Thus, the distinct binding pattern of BAF60c and other BAF subunits on the lipogenic gene promoters in response to feeding, but not in the fasted state, correlates with activation of lipogenic genes and alteration of chromatin structure. Since BAF60c is the specific isoform for lipogenic gene activation, we define the USF-1 interacting BAF subunit, BAF60c, for recruitment of other BAF subunits and thus formation of the lipogenesis specific BAF complex (lipoBAF). Moreover, similar binding patterns of the lipoBAF on lipogenic gene promoters indicate a common key mechanism to induce lipogenic gene transcription in response to fasting/feeding. Coordinate changes in nucleosome structure as detected by nuclease protection assay as well as recruitment of polymerase II to various lipogenic genes upon overexpression and knockdown of BAF60c further support a common mechanism. In this regard, the global gene expression pattern analysis confirmed activation of the lipogenic program by BAF60c in vivo. Furthermore, adenovirus-mediated overexpression and knockdown of BAF60c in mouse livers provided evidence for the BAF60c function in lipogenesis in vivo. The effects of BAF60c on transcription of various lipogenic enzymes were reflected in the changes in de novo lipogenesis, and consequently total hepatic triglyceride content. Overall, our studies demonstrate the importance of BAF60c in the recruitment of lipoBAF to promote lipogenesis.
Phosphorylation-Dependent Translocation of BAF60c in
Response to Insulin Functions as a Regulation for BAF Since BAF complexes govern chromatin remodeling events for transcription, BAF subunits are known to be found in the nucleus. Here, we demonstrate that BAF60c that can be found in the cytosol and is translocated to the nucleus dynamically in response to a physiological signal-feeding/insulin. This BAF60c translocation is regulated by aPKC mediated S247 phosphorylation. In this regard, crosstalk between phosphorylation and translocation is well recognized for transcription factors. However, similar regulation has not previously been proposed or documented for subunits of chromatin remodeling complexes. We show here that translocation of BAF60c to the nucleus in response to feeding/ insulin is dependent on S247 phosphorylation. 
Molecular Cell
BAF60c in Lipogenesis BAF60 has been proposed to bridge between DNA binding transcription factors and chromatin remodeling BAF complexes. However, regulatory mechanisms that permit BAF60 to interact with specific DNA binding transcription factors that will then allow recruitment of BAF complexes have not previously been addressed. In this regard, while phosphorylation of BAF60a or BAF60b has not been reported previously, BAF60c was shown to be phosphorylated at T229 by p38 MAPK (Simone et al., 2004) . However, this phosphorylation affects the interaction of BAF60c with the BAF component, Brg1. The S247 phosphorylation of BAF60c that allows interaction with USF-1 provides a mode by which the BAF complex can be recruited to lipogenic gene promoters in a feeding/insulin dependent manner. Interestingly, S247 of BAF60c, as well as nearby residues, are conserved among mammalian species, but S247 is not found in other BAF60 isoforms. While lower organisms have only one BAF60 that does not contain S247, BAF60c in mammals appears to be the specific subunit involved in forming the lipoBAF complex for the regulation of lipogenesis. We propose that this regulation by BAF60c functions as a dynamic molecular switch in sensing the nutritional transition from fasting to feeding, providing an elegant way to fine tune mammalian lipogenic transcription.
BAF60c Phosphorylation and USF Acetylation Converge the Two Branches of the Insulin Signaling Pathway
It has been well established that PI3K primarily mediates insulin signaling for metabolic regulation. Insulin signaling is mediated by PI3K, which activates PKB/Akt and aPKC (Taniguchi et al., 2006a) . The PI3K pathway also causes activation of PP1 to dephosphorylate target proteins such as DNA-PK that we have shown previously ). Here, we provide evidence that BAF60c links aPKC to activation of lipogenic gene transcription. BAF60c is not regulated at the transcription level, since we did not detect any changes in BAF60c expression in vivo or in cultured cells upon feeding or insulin treatment. However, we detected an increase in BAF60c phosphorylation upon feeding/ insulin. BAF60c is phosphorylated at S247, and our in vitro and in vivo studies clearly show that S247 phosphorylation is abolished by siRNA-mediated knockdown of aPKC or by overexpression of aPKC-DN, pointing evidence to the notion that aPKC is the bona fide kinase for the S247 phosphorylation that occurs during the feeding/insulin condition. Although the link between aPKC and transcriptional activation of lipogenesis is not well understood, our study provides direct evidence that BAF60c bridges the gap. On the other hand, we previously reported that PP1 activates DNA-PK by dephosphorylation. Activated DNA-PK then phosphorylates USF-1 at S262, which then allows K237 acetylation by P/CAF. Although K237 acetylation is critical for lipogenic gene activation, its function was not clear. Here we show that K237 acetylation of USF-1 governs recruitment of BAF60c to the promoters of lipogenic genes. BAF60c can then recruit the other components of the BAF complex to lipogenic gene promoters for chromatin remodeling, an essential step for transcriptional activation. To our surprise, neither the phosphorylation of BAF60c nor the USF phosphorylation at S247 and acetylation at K237 alone is sufficient for their interaction. That interaction requires modification of both BAF60c and USF-1 through different insulin signaling pathways. The regulation of this interaction conceptually represents a ''dance''-like concept that resembles a biological circuit. A high output (interaction in this case) results only if both inputs (USF acetylation and BAF60c phosphorylation) to this biological circuit are high. This regulation provides a way to fine tune an interaction, and it might also operate in other protein-protein interactions that govern various biological processes.
EXPERIMENTAL PROCEDURES
Purification of USF-1 Interacting Proteins, Preparation of Nuclear Extracts, and Cell Fractionation TAP and MS analysis were performed as described previously ). Liver nuclear extracts were prepared by centrifugation through a sucrose cushion in the presence of NaF, and the NE-PER Nuclear and Cytoplasmic extraction kit was used when cytosol was needed for experiments (Thermo).
Chromatin Immunoprecipitation
Livers from fasted or fed mice were fixed with disuccinimidyl glutarate (DSG) (Thermo) at 2 mM for 45 min at room temperature before formaldehyde crosslinking. ChIP was performed as described previously ).
MNase Assay
Cells were crosslinked with 1% formaldehyde, quenched by the addition of glycine, and scraped in NP-40 lysis buffer. Nuclei were collected and treated with MNase. After the addition of proteinase K-containing stop buffer, mononucleosome DNA was purified with a gel extraction kit (QIAGEN). As listed in the Supplemental Experimental Procedures, quantitative PCR (qPCR) primers were designed to span approximately 500 bp regions to generate PCR products of approximately 70 bp with 20 bp overlaps.
In Vitro Phosphorylation
In vitro phosphorylation was performed with recombinant/purified enzymes.
Immunoprecipitation, GST Pull-Down, and Luciferase Reporter Assays Immunoprecipitation of nuclear extracts was performed under standard procedures. GST pull-down was performed as described previously (Griffin Table S1 . et al., 2007) . Luciferase assays were performed in 293FT cells using DualLuc reagent (Promega). NIH image software was used to quantify immunoblotting data.
Confocal Fluorescence Microscopy
In brief, HepG2 cells with or without insulin treatment were fixed with 4% paraformaldehyde in PBS for 10 min and were permeabilized with 0.2% of Triton X-100 for 10 min. After washing, cells were blocked with 1% BSA in PBS for 1 hr and incubated with anti-BAF60c antibody, followed by staining with Alexa Fluor 594 anti-rabbit IgG secondary antibody, and counterstained with DAPI for 5 min. Images were obtained with a Zeiss LSM710 confocal microscope.
RT-PCR Analysis RNA was isolated and reverse transcribed for PCR or qPCR.
De Novo Lipogenesis
Fatty acids were formed during a 24 hr 2 H 2 O body water labeling.
Measurement of Triglyceride Levels
Total neutral lipids were extracted by the Folch method and lipids were solubilized in 1% Triton X-100. Triglyceride levels were measured with Infinity Reagent (Thermo).
All animal procedures were approved by the University of California at Berkeley Animal Care and Use Committee.
Statistical Analysis
The data are expressed as the means ± standard errors, and a Student's t test was used (*p < 0.05 and **p < 0.01).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, three figures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.molcel.2012.10.028.
